Jaypirca is approved for the treatment of adults with relapsed or refractory CLL/SLL who were previously treated with a ...
Neuroblastoma, a rare cancer mainly affecting children, is witnessing advancements in treatments, notably through immunotherapy, which has improved survival rates. Key innovations like gene and CAR-T ...
Susan Ringdal EVP, Strategic Planning and Global Affairs +44 (0)20 7399 2760/ +44 7776 477050 Steven Weiss US Communications +1 732 788 8279 ...
Clinical Trials Arena on MSN
Eli Lilly reports Phase III trial results of Jaypirca for CLL/SLL
The results demonstrated that pirtobrutinib met its primary endpoint of non-inferiority on ORR against ibrutinib.
According to DelveInsight's analysis, the acute on chronic liver failure market is anticipated to increase during the forecast period (2025--2034), owing to the launch of emerging therapies such as ...
The bestselling novel from 'Something Borrowed' author Emily Giffin is headed to the screen—here’s everything we know so far.
“Love, Danielle” is not a documentary, but it incorporates real surgical footage from its co-writer and star, Devin Sidell, ...
A therapy that would once have been considered a feat of science fiction has reversed aggressive and incurable blood cancers ...
Long the titan of prep schools in Los Angeles, with a reputation as an Ivy League feeder, Harvard-Westlake has seen the ...
What was just a few sentences in Stephen King's novel and described in retrospect is now fleshed out with all the necessary ...
AMX-883 (30mg/kg twice daily and 100mg/kg once daily) significantly reduced cancer growth by achieving picomolar potency degradation of BRD9 across a panel of AML cell lines and significantly reduced ...
Bakersfield stands as California’s best-kept secret for retirees – a place where your Social Security check might actually cover your expenses without requiring a side hustle or a wealthy benefactor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results